🟢 Ocugen is trading 5.2% up today amid a broader biotech sector rally

Ocugen is trading 5.2% up at $1.31 today, moving in tandem with a broader biotech sector rally rather than company-specific news.

• The move aligns with the SPDR S&P Biotech ETF (XBI), which is up 2.02% on strong earnings and positive sentiment across peer companies.
• There are no fresh company-specific announcements or regulatory filings tied to the August 5, 2026, session.
• The stock is showing solid intraday gains as investors show increased interest in the biotech space.